Back to APLS

Apellis Pharmaceuticals, Inc. 8-K

Accession 0001193125-23-198578

Filing information

CIK
0001492422
Report date
2023-07-31
Filing date
2023-07-31
Form
8-K
Primary document
d532845d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.